Drug Could Beat Back HIV — If People Could Get It
Cabotegravir is a promising HIV prevention medication that’s approved in countries like the United States. But in sub-Saharan Africa, access encounters a number of hurdles.
Stay updated with breaking news from Mitchell Warren. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cabotegravir is a promising HIV prevention medication that’s approved in countries like the United States. But in sub-Saharan Africa, access encounters a number of hurdles.
South Africa’s medicines regulator will announce a decision on the approval of a two-monthly HIV prevention jab within days. If the shot is approved, the health department could start rolling it out on a large scale within nine months — but that depends on the injection’s price.
South Africa's medicines regulator will announce a decision on the approval of a two-monthly HIV prevention jab within days. If the shot is approved, the health department could start rolling it out on a large scale within nine months - but that depends on the injection's price.
Thabo Molelekwa asked several experts what behaviour change communications should look like in this new era of HIV prevention.